Showing results (91-100 of 144) with videos related to
Sort By:
Pageof 15
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1995
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virusM Opravil, M Pechère, A Lazzarin, et al.HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.Journal of Internal Medicine|February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJ A C Sterne, M May, H C Bucher, et al.Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.AIDS (London, England)|November 4, 2000
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort StudyO T Rutschmann, P L Vernazza, H C Bucher, et al.HIV Medicine|November 26, 2002
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort StudyH C Bucher, M Bichsel, P Taffé, et al.HIV Medicine|October 15, 2013
A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infectionA Mocroft, L Ryom, P Reiss, et al.Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.Pageof 15